新型非骨水泥单髁膝关节置换术早期失败率高
该研究前瞻性收集2021年2月至2022年12月接受新型非骨水泥内侧单髁膝关节置换术的111例患者(127膝)的临床与影像学结局,平均随访0.9年时15膝(11.8%)翻修,最常见翻修原因为无菌性松动(12膝),2.4年Kaplan-Meier生存率为84.0%(95%CI±3.98%)。
要点
- 127膝中15膝(11.8%)翻修,翻修距手术平均0.9年(范围0至2年)
- 最常见翻修原因为无菌性松动,共12膝
- 2.4年Kaplan-Meier生存率为84.0%(95%CI±3.98%)
核心结论
- 这种新型非骨水泥内侧单髁膝关节置换假体早期翻修率高,多为胫骨侧并发症。
- 与未翻修假体相比,翻修假体术后X线片上胫骨和股骨透亮线发生率更高,且翻修前12个月关节置换膝关节损伤与骨关节炎结局评分更低。
- 手术记录中记录到多孔假体表面未见明显骨长入。
研究设计与样本
- 前瞻性收集2021年2月至2022年12月接受新型非骨水泥内侧单髁膝关节置换术的111例患者(127膝)的临床结局,包括患者报告结局指标。
- 从术后X线片评估股骨和胫骨假体周围透亮区。
- 数据在术前及标准术后随访时间点收集,直至最终随访或假体翻修。
主要发现
- 127膝单髁膝关节置换中15膝(11.8%)需要翻修,翻修距手术平均0.9年(范围0至2年)。
- 最常见翻修原因为无菌性松动,共12膝。
- 2.4年Kaplan-Meier生存率为84.0%(95%CI±3.98%)。
- 翻修组与未翻修组12个月关节置换膝关节损伤与骨关节炎结局评分存在显著差异(61.9,95%CI±13.4 对 75.1,95%CI±16.9;P = 0.01)。
- 因无菌性松动翻修的12膝中,11膝的胫骨假体在翻修前影像上可见进展性透亮线。
关键数值与推荐
- 翻修距手术平均0.9年(范围0至2年)。
- 2.4年Kaplan-Meier生存率为84.0%(95%CI±3.98%)。
- 翻修组12个月关节置换膝关节损伤与骨关节炎结局评分为61.9(95%CI±13.4),未翻修组为75.1(95%CI±16.9),P = 0.01。
- 因无菌性松动翻修的12膝中,11膝胫骨假体在翻修前影像上可见进展性透亮线。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unicompartmental knee arthroplasty (UKA) is an accepted treatment for antero-medial osteoarthritis with low overall failure rates. In the United States, cementation remains the gold standard of implant fixation; however, multiple studies have shown potential benefits of increased survivorship with cementless fixation. The aim of this study was to evaluate clinical and radiographic outcomes of a novel cementless medial UKA implant. We hypothesized that cementless UKA would perform as well as or better than cemented UKA. METHODS: Clinical outcomes, including patient-reported outcome measures, were prospectively collected for 111 patients (127 knees) implanted with a novel cementless UKA from February 2021 to December 2022. Radiographic lucency zones surrounding the femoral and tibial components were evaluated from postoperative radiographs. Data were collected preoperatively and at standard postoperative intervals until final follow-up or implant revision. Revisions were necessary in 15 of 127 UKAs (11.8%) at a mean of 0.9 years (range, zero to two). RESULTS: The most common revision reason was aseptic loosening (12). Kaplan-Meier survival was 84.0% (95% CI [confidence interval] ± 3.98%) at 2.4 years. The Knee injury and Osteoarthritis Outcome Score for Joint Replacement 12-month scores differed significantly between revision and nonrevision groups (61.9, 95% CI ± 13.4 versus 75.1, 95% CI ± 16.9; P = 0.01). In patients revised for aseptic loosening, 11 of 12 tibial implants had progressive radiolucent lines on prerevision imaging. Revision operative records noted minimal to no bone ingrowth on the tibial implant undersurface. CONCLUSIONS: This novel cementless medial UKA implant demonstrated a high rate of early revision, mostly for tibial-sided complications. Compared to nonrevised implants, revised implants had higher rates of tibial and femoral radiolucencies on postoperative radiographs as well as lower Knee injury and Osteoarthritis Outcome Score for Joint Replacement 12-month scores prerevision. When recorded in the operative record, no significant bone ingrowth was seen on the porous implant surfaces. LEVEL OF EVIDENCE: IV.
引用
- Bertrand TE, Byrd ZO, Berend KR, et al. High Early Failure Rate of a Novel Cementless Unicompartmental Knee Arthroplasty. J Arthroplasty. 2025. PMID: 39956491. doi:10.1016/j.arth.2025.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。